Search research articles
Contact Us
Filters
Showing results (21-30 of 203) with videos related to
Page
of 21
Sort By:
Journal of Applied Clinical Medical Physics
|
April 14, 2016
Application of dose kernel calculation using a simplified Monte Carlo method to treatment plan for scanned proton beams
Shohei Mizutani, Yoshihisa Takada, Ryosuke Kohno, et al.
Journal of Applied Clinical Medical Physics
|
December 25, 2015
Evaluation of monitor unit calculation based on measurement and calculation with a simplified Monte Carlo method for passive beam delivery system in proton beam therapy
Kenji Hotta, Ryosuke Kohno, Kohsuke Nagafuchi, et al.
Physics in Medicine and Biology
|
August 14, 2013
Experimental verification of dose calculation using the simplified Monte Carlo method with an improved initial beam model for a beam-wobbling system
Ryohei Tansho, Yoshihisa Takada, Ryosuke Kohno, et al.
Brachytherapy
|
March 27, 2020
End-to-end delivery quality assurance of computed tomography-based high-dose-rate brachytherapy using a gel dosimeter
Hidenobu Tachibana, Yusuke Watanabe, Shinya Mizukami, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 9, 2015
Phase II study of proton beam therapy as a nonsurgical approach for mucosal melanoma of the nasal cavity or para-nasal sinuses
Sadamoto Zenda, Tetsuo Akimoto, Masashi Mizumoto, et al.
Molecular and Clinical Oncology
|
January 20, 2017
Effect of combined treatment with micelle-incorporated cisplatin (NC-6004) and S-1 on human gastric cancer xenografts
Masahisa Kudo, Yoshiyuki Yamamoto, Yoshikatsu Koga, et al.
Japanese Journal of Clinical Oncology
|
December 25, 2002
Salvage external beam radiotherapy for local recurrence without systemic progression or prostate specific antigen recurrence of prostate cancer after initial hormonal therapy: is it possible to identify patients likely to have good treatment outcomes?
Kohei Kurokawa, Kazuto Ito, Kazuhiro Suzuki, et al.
World Journal of Clinical Cases
|
December 3, 2020
Erratum: Author's Affiliation Correction. Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor positive gastric cancer (<i>World J Clin Cases</i> 2019; Aug 6; 7 (15): 1964-1977)
Akio Kaito, Takeshi Kuwata, Masanori Tokunaga, et al.
World Journal of Clinical Cases
|
August 20, 2019
HER2 heterogeneity is a poor prognosticator for HER2-positive gastric cancer
Akio Kaito, Takeshi Kuwata, Masanori Tokunaga, et al.
Pancreas
|
August 13, 2019
Expression of Monocarboxylate Transporter 1 Is Associated With Better Prognosis and Reduced Nodal Metastasis in Pancreatic Ductal Adenocarcinoma
Aoi Sukeda, Yuka Nakamura, Yasunori Nishida, et al.
Page
of 21
Search research articles
Search
Showing results (21-30 of 203) with videos related to
Sort By:
Page
of 21
Journal of Applied Clinical Medical Physics
|
April 14, 2016
Application of dose kernel calculation using a simplified Monte Carlo method to treatment plan for scanned proton beams
Shohei Mizutani, Yoshihisa Takada, Ryosuke Kohno, et al.
Journal of Applied Clinical Medical Physics
|
December 25, 2015
Evaluation of monitor unit calculation based on measurement and calculation with a simplified Monte Carlo method for passive beam delivery system in proton beam therapy
Kenji Hotta, Ryosuke Kohno, Kohsuke Nagafuchi, et al.
Physics in Medicine and Biology
|
August 14, 2013
Experimental verification of dose calculation using the simplified Monte Carlo method with an improved initial beam model for a beam-wobbling system
Ryohei Tansho, Yoshihisa Takada, Ryosuke Kohno, et al.
Brachytherapy
|
March 27, 2020
End-to-end delivery quality assurance of computed tomography-based high-dose-rate brachytherapy using a gel dosimeter
Hidenobu Tachibana, Yusuke Watanabe, Shinya Mizukami, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 9, 2015
Phase II study of proton beam therapy as a nonsurgical approach for mucosal melanoma of the nasal cavity or para-nasal sinuses
Sadamoto Zenda, Tetsuo Akimoto, Masashi Mizumoto, et al.
Molecular and Clinical Oncology
|
January 20, 2017
Effect of combined treatment with micelle-incorporated cisplatin (NC-6004) and S-1 on human gastric cancer xenografts
Masahisa Kudo, Yoshiyuki Yamamoto, Yoshikatsu Koga, et al.
Japanese Journal of Clinical Oncology
|
December 25, 2002
Salvage external beam radiotherapy for local recurrence without systemic progression or prostate specific antigen recurrence of prostate cancer after initial hormonal therapy: is it possible to identify patients likely to have good treatment outcomes?
Kohei Kurokawa, Kazuto Ito, Kazuhiro Suzuki, et al.
World Journal of Clinical Cases
|
December 3, 2020
Erratum: Author's Affiliation Correction. Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor positive gastric cancer (<i>World J Clin Cases</i> 2019; Aug 6; 7 (15): 1964-1977)
Akio Kaito, Takeshi Kuwata, Masanori Tokunaga, et al.
World Journal of Clinical Cases
|
August 20, 2019
HER2 heterogeneity is a poor prognosticator for HER2-positive gastric cancer
Akio Kaito, Takeshi Kuwata, Masanori Tokunaga, et al.
Pancreas
|
August 13, 2019
Expression of Monocarboxylate Transporter 1 Is Associated With Better Prognosis and Reduced Nodal Metastasis in Pancreatic Ductal Adenocarcinoma
Aoi Sukeda, Yuka Nakamura, Yasunori Nishida, et al.
Page
of 21